Atrium Medical establishes new specialty healthcare division

Atrium Biosurgery is engaged in the development of advancements in biological, mechanical and therapeutic solutions for soft tissue healing following trauma, surgery and or other interventional procedures that require improved patient recovery and prospects for improved healing outcomes.

According to Atrium, this new global expansion will complement its other professional healthcare divisions – cardiovascular interventions and cardiothoracic surgery – by continuing the company’s tradition of providing medical device technology for patients around the globe.

Atrium Biosurgery products include Atrium’s first-to-market Omega 3 bioabsorbable oil fatty acid (O3FA) coated medical devices. This novel technology combines Atrium’s ProLite and ProLite Ultra brand polypropylene surgical mesh products commonly used in soft tissue and hernia repair with a proprietary, pharmaceutical grade Omega 3 bio-absorbable coating.